Embracing Accessibility: The Future Of Clinical Trials

By Bryan McDowell, M.Sc., M.B.A. – VP, eCOA Science and Consulting at Clario

Participating in clinical trials should be a seamless experience for patients, and as technology plays an increasingly significant role in these studies, the usability and functionality of these technologies become pivotal factors in enhancing the patient's journey.

It's widely recognized that an improved patient experience, coupled with technology that's easy to use, leads to higher data quality, greater retention, improved compliance, and better adherence to the study protocol. For individuals with impairments, such as vision issues, the ability to utilize technology for recording study outcomes and participating in clinical trials may become more challenging without the necessary features, such as larger text and zoom-in/zoom-out options.

Access the full article below to better understand why accessibility stands as a crucial pillar for the prosperity of the biopharmaceutical and clinical research sector, having evolved into an all-encompassing industry imperative. In a world where inclusivity and diversity in medical research take center stage, falling behind is an outcome we cannot afford.